LY2624803

LY2624803 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LY2624803, covering 2011-06-03 to 2016-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2624803 in Japanese Participants With Transient Insomnia [Phase 1]